Metabolic Recovery with the Persistence of Proinflammatory Leucocyte Dysfunction After Bariatric Intervention for Obesity

Obes Surg. 2024 May;34(5):1575-1583. doi: 10.1007/s11695-024-07135-2. Epub 2024 Mar 4.

Abstract

Purpose: A suitable option for severe obesity treatment is a surgical approach. After surgery, metabolic markers and weight frequently return to adequate values; however, concerning systemic inflammatory mediators, the results are inconsistent. Furthermore, it has been suggested that leucocyte function may be affected even after weight normalization. This study aimed to determine if the surgical treatment of obesity influences the production of cytokines by LPS-stimulated as a function of leucocytes.

Materials and methods: We performed a cross-sectional study that investigated the production of cytokines in response to lipopolysaccharide (LPS) along a kinetic of simulation by leucocytes recovered from individuals with normal weight (NW, n = 8), persons living with obesity (Ob, n = 7), persons living with obesity and diabetes mellitus (Ob-DM, n = 17), and persons that used to live with obesity who underwent bypass surgery (fOb + bypass, n = 8) and recover normal weigh.

Results: IL-6 levels were significantly higher in the Ob and fOb + bypass groups than in NW (p = 0.043). IL-10 secretion without LPS was significantly higher in the NW group than in the other groups explored (p < 0.05). When exposed to LPS, the IL-10 levels increased in all groups except the NW group. As also observed for IL-18 and IL-33, the secretion curve of the fOb + bypass group was more similar to the Ob group, even when they had reached normal weight, as opposed to the NW group.

Conclusion: Our results show that in patients with fOb + bypass, inflammatory and anti-inflammatory cytokine production dynamics remain disrupted even with improved metabolic control and normal weight recovery.

Keywords: Bypass; Cytokine production; DM; Leucocyte dysfunction; Metabolic syndrome; Obesity.

MeSH terms

  • Bariatrics*
  • Cross-Sectional Studies
  • Cytokines
  • Humans
  • Interleukin-10
  • Lipopolysaccharides / pharmacology
  • Obesity / metabolism
  • Obesity, Morbid* / surgery

Substances

  • Interleukin-10
  • Lipopolysaccharides
  • Cytokines